Vicarious Surgical, a humanoid robot surgeon startup is planning to develop a tiny humanoid robot that can be placed inside the body of the patient with help of small incision, and allowing it to be controlled regardless of the place while using virtual reality system that will be connected to the robot surgeon.
The aim is to perform surgeries on patients using a robot from anywhere regardless of the distance between patient and surgeon, this is also likely to reduce the cost of higher impact surgeries. The new system by the company will allow surgeons to see using the robot camera or robot eye and also control the arm of the robot by simply moving their own arm.
Vicarious Surgical has been founded by the graduates from Massachusetts Institute of Technology and the company has already raised an additional $10 million in the funding that was led by Bill Gates Frontier Fund. Meanwhile, other investors include AME Cloud Ventures, Salesforce founder Benioff and Neil Devani of Singularity Holdings VC, Khosla capital firm, and Innovation Endeavors LLC. The company has raised about $31.8 million in funding in total for the development of new technology.
Request For Report Sample@ https://www.persistencemarketresearch.com/samples/25117
The company is combining robots technology with virtual reality to develop new product and plans to use the fund in redefining the process. The co-founders of Vicarious Surgical have been working on the technology for nearly five years. The team is working on ways to miniaturize robotics and put motion of surgery in the abdominal cavity. The team plans to target on how the technology can improve healthcare in remote areas. However, currently, the aim is to reduce the size of robots and place it in patient’s body while allowing it to be controlled virtually.
With high precision and better patient outcomes combined with minimally invasive nature, microsurgery robots are being adopted on a large scale for microsurgeries. Meanwhile, minimum blood loss, reduced pain, and fast recovery are some of the important advantages of microsurgery robots, resulting in the growing adoption across various countries. Resulting in superior outcomes, microsurgery robots are being widely used in urology surgery as compared to laparoscopic and open urology procedures.
Neurosurgery is also moving towards using microsurgery robots owing to the addition of high precision and minimum complications. Moreover, reconstructive surgery is also driving demand for microsurgery robots owing to the development of new systems in microsurgery robots for reconstructive procedures. Owing to the growing adoption across various surgical procedures, the microsurgery robots market is projected to surpass US$ 1,562.9 million by the end of 2028. Manufacturers in the microsurgery robots market with the aim to offer advanced devices are acquiring small and local research and development companies with a focus on surgical robots technology.
Request For Report Table of Content (TOC)@ https://www.persistencemarketresearch.com/methodology/25117
With advanced technologies in healthcare and the presence of a large number of manufacturers in North America, it is likely to emerge as the lucrative region in the microsurgery robots market. Meanwhile, increasing healthcare expenditure, and increasing focus on advanced surgical devices in CIS & Russia is expected to surge the demand for advanced microsurgery robots and devices.